4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-055434
Chief Development Officer acquired 434 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longpre Lara Chief Development Officer | 2023-11-10 | Grant or award | +434 | $22.29 | $9,673 | 106,273 | D: show line 1 in the form |
Loading xslF345X05/doc4.xml…